Skip to main content

Page of 2 next disabled
and
  1. No Access

    Article

    Intérêt de la mesure individualisée de la qualité de vie en oncologie: utilisation du SEIQoL chez des patients traités pour tumeur neuro-endocrine

    Les mesures individualisées de qualité de vie en oncologie peuvent apporter des informations spécifiques et complémentaires à celles qui sont issues des mesures standardisées de qualité de vie. Cet article ill...

    C. Rodary, S. Dauchy, C. Beauvallet, M. Ducreux in Revue Francophone de Psycho-Oncologie (2005)

  2. No Access

    Article

    Sodium iodide symporter expression and radioiodine distribution in extrathyroidal tissues

    The functional role of the sodium iodide symporter (NIS) in extrathyroidal tissues was investigated by examining its mRNA and protein expression, together with the evidence of radioiodine (131I) uptake in 302 pat...

    R. Bruno, P. Giannasio, G. Ronga, E. Baudin in Journal of Endocrinological Investigation (2004)

  3. Article

    Open Access

    Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging

    Imaging-detected relapses are observed in a significant proportion of patients with medullary thyroid carcinoma (MTC) with normal postoperative imaging studies. The aim of this study was to search for prognost...

    G Pellegriti, S Leboulleux, E Baudin, N Bellon, C Scollo in British Journal of Cancer (2003)

  4. Article

    Open Access

    Chromogranin A and the α-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma

    Using specific immunoradiometric assays, we evaluated the clinical usefulness of chromogranin A and the α-subunit of glycoprotein hormones in neuroendocrine tumours of neuroectodermic origin. The serum α-subun...

    L Guignat, J M Bidart, M Nocera, E Comoy, M Schlumberger in British Journal of Cancer (2001)

  5. Article

    Open Access

    Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine

    Combinations of doxorubicin and streptozocin and 5-FU and dacarbazine were given alternately to 20 patients with metastatic medullary thyroid carcinoma. Three partial responses and 10 long-term stabilizations ...

    M Nocera, E Baudin, G Pellegriti, A F Cailleux in British Journal of Cancer (2000)

  6. Article

    Open Access

    Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin

    The purpose of this study was to evaluate by a retrospective analysis of 53 patients the efficacy of chemotherapy combining etoposide and cisplatin in the treatment of neuroendocrine tumours. The regimen was a...

    E Mitry, E Baudin, M Ducreux, J-C Sabourin, P Rufié in British Journal of Cancer (1999)

  7. No Access

    Article

    Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours

    Circulating neuron-specific enolase (NSE) and chromogranin A (CgA) were measured in 128 patients with neuroendocrine tumours (NET) to compare their sensitivity and specificity, to investigate factors associate...

    E Baudin, A Gigliotti, M Ducreux, J Ropers, E Comoy in British Journal of Cancer (1998)

  8. No Access

    Article

    Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma

    Adrenocortical carcinoma (ACC) is a rare tumour with a poor prognosis. Cisplatin is the most widely tested cytotoxic agent in this disease. A total of 18 patients with advanced ACC were enrolled. Cytotoxic the...

    R Bonacci, A Gigliotti, E Baudin, N Wion-Barbot, P Emy in British Journal of Cancer (1998)

Page of 2 next disabled